About Prometheus Therapeutics
Prometheus Therapeutics is a private company based in Miramar, Florida. It has reported $11,559,505 raised in four offerings on Form D since September 2020. Its chief executive is Ajay Wakhloo.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 28, 2025 | Nov 12, 2025amended Apr 15, 2026 | $2,745,000of $6.5M target | 13 | $211K | OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 31, 2023 | Feb 13, 2023amended Jun 21, 2024 | $8,182,398of $8.3M target | 46 | $177K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Jul 21, 2022 | Jul 26, 2022 | $345,000fully sold | 8 | $43,125 | Debt, OptionsRule 506(b) | Form D ↗ |
| Aug 24, 2020 | Sep 8, 2020 | $287,107of $697K target | 7 | $41,015 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $11,559,505 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Prometheus Therapeutics's Form D filed Apr 15, 2026.
AH
Alexander Hastings
Director
BN
Ajay Wakhloo
CEO and director
Also a director at Deinde Medical and a chief executive officer and director at NeuroFine.
JM
Earlier filings also listed Marc Litzenberg (executive officer and director, last listed Jun 2024) and Bernardo Navarro (executive officer, last listed Jun 2024).